Outcomes and mutational analysis of patients with lower-risk non-del5q myelodysplastic syndrome treated with antithymocyte globulin with or without ciclosporine A
Titel:
Outcomes and mutational analysis of patients with lower-risk non-del5q myelodysplastic syndrome treated with antithymocyte globulin with or without ciclosporine A
Auteur:
Kelaidi, C. Braun, T. Arana, R. Marceau-Renaut, A. Lazarian, G. Soret, J. Cereja, S. Letestu, R. Eclache, V. Lusina, D. Baran-Marszak, F. Ades, L. Preudhomme, C. Martin, A. Fenaux, P. Gardin, C.